Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Norvo Nordisk, a global healthcare company, is currently involved in a product liability lawsuit against its Ozempic brand, a ...

Ozempic, a popular weight-loss drug, has helped many shed pounds and improve their health. However, discontinuing the ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Ozempic can help with blood sugar management, aid with significant weight loss, and perhaps even treat opioid use disorder.

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Online conversations about Ozempic and similar medications are full of misinformation — and echo decades of flawed teachings ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...